Eyevensys

EYEVENSYS is a Clinical stage company developing innovative non-viral gene therapies using proprietary electro transfection system. Eyevensys’ technology is based on using electransfection to deliver protein coding plasmids into the ciliary muscle of the eye. This enables the sustainable local production of therapeutic proteins. This approach is based around Eyevensys’ EyeCET platform that uses Eyevensys’ proprietary electro-transfection injection system (ETIS) to deliver the plasmids that encode for the production of therapeutic proteins in the ciliary muscle of the eye . The Company’s goal is to build a high-value product pipeline by enabling sustained production of a number of therapeutic proteins in the eye thus improving clinical outcome and reducing the burden of frequent intravitreal or systemic injections.